-
Signature
-
/s/ Philip LoScalzo, as Attorney-in-Fact
-
Issuer symbol
-
IBRX
-
Transactions as of
-
23 Feb 2026
-
Net transactions value
-
-$175,500
-
Form type
-
4
-
Filing time
-
24 Feb 2026, 20:05:58 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Selecky Christobel |
Director |
C/O IMMUNITYBIO, INC., 3530 JOHN HOPKINS COURT, SAN DIEGO |
/s/ Philip LoScalzo, as Attorney-in-Fact |
24 Feb 2026 |
0001849739 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IBRX |
Common Stock |
Options Exercise |
$74,500 |
+25,000 |
|
$2.98 |
25,000 |
23 Feb 2026 |
Direct |
|
| transaction |
IBRX |
Common Stock |
Sale |
$250,000 |
-25,000 |
-100% |
$10.00 |
0 |
23 Feb 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
IBRX |
Stock Option (right to buy) |
Options Exercise |
$0 |
-25,000 |
-27% |
$0.000000 |
67,937 |
23 Feb 2026 |
Common Stock |
25,000 |
$2.98 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: